Preview

Pediatric pharmacology

Advanced search

Gluten-Free Diet in Children with Dermatologic Pathology

https://doi.org/10.15690/pf.v19i1.2346

Abstract

Background. Gluten-free diet (GFD) is a nutritional pattern that excludes such component of grain crops as gluten. This diet administration should be strictly regulated due to its influence on the growing child nutritional status and on the course of skin diseases. Thus, studying the effects of GFD on the course of dermatologic diseases in various patients’ groups is crucial.

Objective. The aim of the study is to study the effects of GFD on nutritional status and skin condition of patients with dermatologic pathology and associated celiac disease, as well as gluten hypersensitivity.

Methods. The study included children hospitalized in the dermatology department. We have used obtained anthropometric data (weight, height, body mass index (BMI)) to estimate nutritional status, all calculations were performed via programs WHO Anthro (for children under 5 years old) and WHO AntroPlus (for children over 5 years old). Weight-for-age (WAZ), height-for-age (HAZ), BMI-for-age (BAZ) z-scores were evaluated. Estimation of skin pathological process was performed via SCORAD index for patients with atopic dermatitis, PASI — for psoriasis, SALT — for alopecia, VASI — for vitiligo, LoSCAT — for scleroderma. Assessment of anthropometric measures and skin disease severity was performed at study initiation and 6 months after nutrition correction.

Results. 1000 children with various dermatologic pathologies admitted to the dermatology department during the period from August 2020 to August 2021 were examined. Three patients’ groups were formed: with celiac disease, gluten hypersensitivity, and without any gluten-associated conditions. Assessment of anthropometric measures has shown positive dynamics in patients with celiac disease and gluten hypersensitivity on GFD, as well as in patients without any gluten-associated conditions on normal caloric diet according to age norms. All three groups have shown positive dynamics for skin pathologies.

Conclusion. Estimation of nutritional status and skin conditions on various stages of the study has shown the importance of differentiated approach in GFD administration in dermatologic patients.

About the Authors

Leonid A. Opryatin
National Medical Research Center of Children’s Health
Russian Federation

MD, eLibrary SPIN: 1851-2361

Moscow


Disclosure of interest:

confirmed the absence of a reportable conflict of interests



Tatiana E. Borovik
National Medical Research Center of Children’s Health; Sechenov First Moscow State Medical University
Russian Federation

MD, PhD, Professor; eLibrary SPIN: 1777-2118

Moscow


Disclosure of interest:

confirmed the absence of a reportable conflict of interests



Nikolay N. Murashkin
National Medical Research Center of Children’s Health; Sechenov First Moscow State Medical University; Central State Medical Academy
Russian Federation

MD, PhD, Professor; eLibrary SPIN: 5906-9724


Disclosure of interest:

Receiving research grants from pharmaceutical companies Jansen, Eli Lilly, Novartis, Abbvi, Pfizer, Amryt Pharma plc. Scientific consultant of Galderna, Pierre Fabre, Bayer, Leofarma, Pfizer, AbbVie, Zeldis Pharma LLC companies



References

1. Humbert P, Pelletier F, Dreno B, et al. Gluten intolerance and skin diseases. Eur J Dermatol. 2006;16(1):4–11.

2. Bonciolini V, Bianchi B, Del Bianco E, et al. Cutaneous manifestations of non-celiac gluten sensitivity: Clinical histological and immunopathological features. Nutrients. 2015;7(9):7798–7805. doi: https://doi.org/10.3390/nu7095368

3. Losurdo G, Principi M, Iannone A, et al. Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm. World J Gastroenterol. 2018;24(14):1521–1530. doi: https://doi.org/10.3748/wjg.v24.i14.1521

4. Catassi C, Bai JC, Bonaz B, et al. Non-Celiac Gluten sensitivity: The new frontier of gluten related disorders. Nutrients. 2013;5(10):3839–3853. doi: https://doi.org/10.3390/nu5103839

5. Catassi C, Elli L, Bonaz B, et al. Diagnosis of Non-Celiac Gluten Sensitivity (NCGS): The Salerno Experts’ Criteria. Nutrients. 2015;7:4966–4977. doi: https://doi.org/10.3390/nu7064966

6. Leffler DA, Green PH, Fasano A. Extraintestinal manifestations of coeliac disease. Nat Rev Gastroenterol Hepatol. 2015;12(10): 561–567. doi: https://doi.org/10.1038/nrgastro.2015.131

7. Hadjivassiliou M, Grünewald RA, Davies-Jones GA. Gluten sensitivity as a neurological illness. J Neurol Neurosurg Psychiatry. 2002;72(5):560–563. doi: https://doi.org/10.1136/jnnp.72.5.560

8. Spencer J, Sollid LM. The human intestinal B-cell response. Mucosal Immunol. 2016;9(5):1113–1124. doi: https://doi.org/10.1038/mi.2016.59

9. Jabri B, Sollid LM. T Cells in Celiac Disease. J Immunol. 2017;198(8): 3005–3014. doi: https://doi.org/10.4049/jimmunol.1601693

10. Child growth standards. In: World Health Organization. Available online: http://www.who.int/childgrowth/software/en. Accessed on February 22, 2022.

11. Severity of scoring of atopic dermatitis: the SCORAD index. Consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1993;186(1):23–31. doi: https://doi.org/10.1159/000247298


Review

For citations:


Opryatin L.A., Borovik T.E., Murashkin N.N. Gluten-Free Diet in Children with Dermatologic Pathology. Pediatric pharmacology. 2022;19(1):27-32. (In Russ.) https://doi.org/10.15690/pf.v19i1.2346

Views: 681


ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)